摘要
目的探讨经皮冠状动脉介入治疗（PCI）术前血红蛋白水平对冠心病术后1年死亡率的影响。方法选取初次在北京大学人民医院2006年1月1日-2009年12月31日成功接受经皮冠状动脉介入治疗并成功接受1年随访的1203名患者为研究对象，记录患者人院时的临床资料、实验室检查及介入资料等基线资料，根据患者术后1年时是否死亡（全因死亡）将患者分为死亡组和未死亡组，比较两组患者术前血红蛋白水平，并分析术前血红蛋白水平与PCI术后1年患者死亡率的关系。结果PCI术后死亡患者15名（1．3％），PCI术前血红蛋白水平低于正常值的患者97名（8.1％），术后1年死亡组患者血红蛋白水平明显低于未死亡组患者（P=0．013），Logistic回归分析显示：术前血红蛋白水平越低的患者，术后1年死亡率越高俨=0．033，OR=0．970，95％CI=0．944—0．998）。结论术前血红蛋白水平是影响冠心病患者经皮冠状动脉介入治疗预后的相关因素。
Objective To investigate the effect of hemoglobin levels with mortality in patients after 1 year of percutaneous coronary intervention. Methods The follow-up was performed in 1203 patients undergoing PCI for first time in Peking University people＇s hospital between January 1,2006 and December 31,2009.The patients were divided into two groups according to whether patients died. The hemoglobin levels of two groups were compared. Results 15 patients died after 1 year of PCI. The hemoglobin of dead patients was lower（P=0.013）. The hemoglobin levels were significant correlation with the mortality in patients after 1 year of percutaneous coronary intervention（P=0.033, OR=0.970, 95%CI= 0.944-0.998）. Conclusion The hemoglobin level is one of the risk factors of the mortality in patients after 1 year of percutaneous coronary intervention.
出处
《继续医学教育》
2013年第10期17-19,共3页
Continuing Medical Education
